Report covers take-home points from the 2017 Gut Microbiota for Health World Summit in Paris
19 Jul 2017by GMFH Editing Team
The GMFH editing team is pleased to bring you the Gut Summit 2017 official report.
GMFH releases Nutrition and Gut Microbiota Workshop report from 6th Gut Microbiota for Health World Summit
19 Jul 2017by GMFH Editing Team
The workshop —called “Nutrition and the human gut microbiome: What should health professionals know for their daily practice?”— addressed issues and questions relevant to nutrition practice.
Researchers find the first evidence of brain structural alterations correlated with gut microbes in people with irritable bowel syndrome
29 May 2017by Andreu Prados
A new study has found that gut microbial composition may be associated with brain structural alterations in people with IBS.
Researchers identify intestinal microbiota profile related to severity of IBS symptoms
21 Dec 2016by Andreu Prados
A recent study, led by Prof. Magnus Simrén from the Department of Internal Medicine & Clinical Nutrition and University of Gothenburg Centre for Person-Centered Care at the University of Gothenburg in Gothenburg (Sweden), has identified a gut microbiota profile that is related to the severity of IBS symptoms.
The oral microbiota as a potential source of information in irritable bowel syndrome
12 Sep 2016by Andreu Prados
A recent study, led by Dr. Wendy A. Henderson from the National Institute of Nursing Research at National Institutes of Health (NIH) in Bethesda (USA), and co-authored by Research Fellow Dr. Nicolaas Fourie, has found that the oral microbiota could be a useful source of information in patients with irritable bowel syndrome (IBS).
Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, affecting more than 10% of the population, with the highest impact in women. Although its origin is still unknown, reduced gut microbial diversity could be involved in its development.
Authors of this paper attempted a meta-analysis of 56 studies on single-strain and multi-strain probiotics for the treatment of IBS, but trials were so heterogeneous when it came to probiotic concentration, duration of treatment, and methodology, that the meta-analysis was abandoned.
In new understandings of IBS, diet and probiotics emerging as promising treatments
2 Oct 2015by Kristina Campbell
When talking about irritable bowel syndrome [IBS], Dr. Eamonn Quigley eschews the term 'functional disorder'. For Quigley, a gastroenterologist and researcher at Houston Methodist Hospital (USA), it's only a matter of time before the disordered physiology of IBS becomes clear.
Previous research has shown that adults with irritable bowel syndrome (IBS) who adopt a low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet show an improvement in symptoms within 2 days. Would the low FODMAP diet have the same effect in childhood IBS? Does the gut microbiota predict the success of the diet in children who respond to this dietary intervention?
Dysbiosis -- an abnormal gut microbiota -- is associated with several diseases, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).
